9:22 AM
Leo Group India
| ||
| Sun Pharmaceutical Industries Q1 net jumps 59 pct on US sales Economic Times Sun Pharmaceutical Industries, India's top drugmaker by market capitalisation, reported 59 per cent rise in quarterly net profit substantially beating street estimates, as sales in its key U.S. market surged helped by robust business of Israeli unit ... See all stories on this topic » | ||
| Researchers say pharmaceutical "innovation crisis" is a myth Philadelphia Inquirer (blog) Using their own work and citing others, Light and Lexchin argue that pharmaceutical companies, especially large ones, have a "hidden" strategy of producing safely profitable drugs that buffer patent cliff losses on new and distinct medicine, though ... See all stories on this topic » | ||
| Supernus Pharmaceuticals Reports Second Quarter 2012 Financial Results NASDAQ 10, 2012 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, today reported consolidated financial results for the three and six months ending June 30, 2012, and provided an update on key ... See all stories on this topic » | ||
| First-time MP, Jyoti Mirdha makes life difficult for pharmaceutical companies ... Economic Times NEW DELHI: If pharmaceutical companies and drug regulators in India have been lately facing scrutiny in greater and vicious doses, some of it can be traced to the dogged inquisitions of a young, first-time parliamentarian: Jyoti Mirdha. This Congress ... See all stories on this topic » | ||
| AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results Sacramento Bee 9, 2012 -- /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today ... See all stories on this topic » | ||
| KV Pharmaceutical Use of Cash Collateral Approved by US Bankruptcy Court RedOrbit 10, 2012 /PRNewswire/ — K-V Pharmaceutical Company ("K-V" or "the Company") announced that the U.S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, today approved on an interim basis the ... See all stories on this topic » | ||
| Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter ... Equities.com Mr. Jinsheng Ren, Chairman and Chief Executive Officer of Simcere Pharmaceutical Group said, "In the second quarter of 2012, Simcere's revenue and gross margin remained largely stable. While sales of edaravone, Endu and Sinofuan continued to grow ... See all stories on this topic » | ||
| 5 Pharmaceutical Companies With Phase III Clinical Study Catalysts This Year Seeking Alpha Pharmaceutical companies with a set Phase III data release dates usually have a runup leading into the release date. I usually try to buy the stocks 3-9 months before the catalyst date to make profit from the runup. I screened for companies that have a ... See all stories on this topic » | ||
| Teva reports 19% increase in Q2 revenues RTE.ie Teva, a global pharmaceutical company which employs almost 500 people in Ireland, has reported a 19% increase in its second-quarter revenues over the same time last year. 1 of 1. The company says it is on track to achieve further growth this year ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment